Yibo Li1, Fangwei Liu2, Armin Badre2. 1. Departments of Surgery (Li, Badre) and Family Medicine (Liu), and Western Upper Limb Facility (Badre), University of Alberta, Edmonton, Alta. li4@ualberta.ca. 2. Departments of Surgery (Li, Badre) and Family Medicine (Liu), and Western Upper Limb Facility (Badre), University of Alberta, Edmonton, Alta.
Lateral epicondylosis (tennis elbow) is a degenerative, noninflammatory condition of the common extensor origin at the lateral epicondyle of the elbow
Tennis elbow has a prevalence of 1%–3%, peaking at age 35–50 years.1 It is associated with smoking and with a combination of repetitive and forceful manual activities.2
The diagnosis is clinical based on lateral elbow pain and epicondyle tenderness
Provocative tests include pain with resisted extension of the long fingers or wrist when the elbow is extended. Pain distal to the epicondyle suggests radial tunnel syndrome and warrants orthopedic referral. Clinicians should obtain radiographs for patients with loss of range of motion, locking or catching of the elbow to assess for osteoarthritis and osteochondritis dissecans. Ultrasonography and magnetic resonance imaging have variable sensitivity and specificity, and are not routinely required.1
Symptoms of tennis elbow are managed with physiotherapy and anti-inflammatory agents
Eccentric strengthening of the common extensor origin (Appendix 1, available at www.cmaj.ca/lookup/doi/10.1503/cmaj.211047/tab-related-content) reduces pain and improves function and grip strength.2 Topical nonsteroidal anti-inflammatory drugs (NSAIDs) reduce pain (number needed to treat = 7) with few adverse effects, but oral NSAIDs provide unclear benefit with a risk of gastrointestinal adverse effects.3
Corticosteroid injections should be avoided
Corticosteroid injections provide only short-term pain relief and result in lower rates of symptom resolution or improvement (number needed to harm [NNH] = 8) and greater risk of symptom recurrence (NNH = 2) than placebo injections at 1 year.4 The efficacy of platelet-rich plasma is unclear, given variation in its preparation and lack of superiority to placebo in underpowered studies.5
Referral for surgery should be considered after 6 months of failed nonoperative management
Tennis elbow is usually self-limiting, and 90% of patients recover within 1 year. Those who do not respond after 6 months of nonoperative treatment are likely to have a prolonged disease course of more than 2 years and are potential candidates for surgery.6 Open, arthroscopic or percutaneous débridement of the common extensor origin has been shown to improve pain and function scores, with good-to-excellent outcomes in 80% of patients.6CMAJ invites submissions to “Five things to know about …” Submit manuscripts online at http://mc.manuscriptcentral.com/cmaj
Authors: Thomas L Sanders; Hilal Maradit Kremers; Andrew J Bryan; Jeanine E Ransom; Jay Smith; Bernard F Morrey Journal: Am J Sports Med Date: 2015-02-05 Impact factor: 6.202